Journal Mobile Options
Table of Contents
Vol. 85, No. 3-4, 1999
Issue release date: 1999
Cytogenet Cell Genet 85:310–314 (1999)

The novel contiguous gene syndrome of myotubular myopathy (MTM1), male hypogenitalism and deletion in Xq28:report of the first familial case

Bartsch O. · Kreß W. · Wagner A. · Seemanova E.
aInstitut für Klinische Genetik, Klinikum Carl Gustav Carus der Technischen Universität Dresden, Dresden; bInstitut für Humangenetik der Universität Würzburg, Würzburg (Germany); cDepartment of Clinical Genetics, Charles University Motol Hospital, Prague (Czech Republic)

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in



Hu et al. (1996) and Laporte et al. (1997) recently proposed a novel contiguous gene syndrome of myotubular myopathy, abnormal male genital development and deletion in Xq28. We studied a family where two male infants, both deceased, had myotubular myopathy and intersexual genitalia. Using FISH we detected in the mother a hemizygous deletion including the myotubularin gene MTM1 and F18 (a gene of yet unknown function). DNA studies with STR-markers (short tandem repeats) within and flanking the deleted segment confirmed the deletion in the family and were used for prenatal diagnosis. Our findings confirm the existence of this novel contiguous gene syndrome and support that the deletion of the F18 gene, or a neighboring gene, may cause ambiguous genitalia or severe hypospadias in males. The mother had low muscle power and marked menstrual irregularities which may indicate that she is a manifesting carrier and that the deletion may include a gene (F18 or other) for gonadal function in females.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen receptor gene correlates with X-chromosome inactivation. Am J hum Genet 51:1229–1239 (1992).
  2. Barth PG, Dubowitz V: X-linked myotubular myopathy – a long-term follow-up study. Eur J Paediatr Neurol 1:49–56 (1998).
  3. Bartsch O, Hinkel GK, Petersen MB, König U, Bugge M, Mikkelsen M, Avramopoulos D, Morris M, Antonarakis SE: A large family with subtelomeric translocation t(18;21)(q23;q22.1) and molecular breakpoint in the Down syndrome critical region. Hum Genet 100:667–674 (1997).
  4. Bartsch O, Kuhnle U, Werner W, Seemanová E: Molecular cytogenetic mapping of two new genes for hypospadias on chromosomes 13q33.2→qter and Xq28. Eur J Pediatr 157:175 (1998).
  5. Dahl N, Hu LJ, Chery M, Fardeau M, Gilgenkrantz S, Nivelon-Chevallier A, Sidaner-Noisette I, Mugneret F, Gouyon JB, Gal A, Kioschis P, d’Urso M, Mandel JL: Myotubular myopathy in a girl with a deletion at Xq27→q28 and unbalanced X inactivation assigns the MTM1 gene to a 600-kb region. Am J hum Genet 56:1108–1115 (1995).

    External Resources

  6. Darnfors C, Borje Larsson HE, Oldfors A, Kyllerman M, Gustavson KH, Bjursell G, Wahlstrom J: X-linked myotubular myopathy: a linkage study. Clin Genet 37:335–340 (1990).

    External Resources

  7. Fitch N, de Saint Victor J, Richer CL, Pinsky L, Sitahal S: Premature menopause due to a small terminal deletion in the long arm of the X chromosome: a report of three cases and a review. Am J Obstet Gynecol 142:968–972 (1982).

    External Resources

  8. Fryns JP, Kleczkowska A, Petit P, van den Berghe H: Fertility in patients with X chromosome deletions. Clin Genet 22:76–79 (1982).
  9. Geerkens C, Just W, Vogel W: Deletions of Xq and growth deficit: a review. Am J med Genet 50:105–113 (1994).

    External Resources

  10. de Gouyon BM, Zhao W, Laporte J, Mandel JL, Metzenberg A, Herman GE: Characterization of mutations in the myotubularin gene in twenty six patients with X-linked myotubular myopathy. Hum molec Genet 6:1499–1504 (1997).
  11. Heckmatt JZ, Sewry CA, Hodes D, Dubowitz V: Congenital centronuclear (myotubular) myopathy: a clinical, pathological and genetic study in eight children. Brain 108:941–964 (1985).

    External Resources

  12. Hu LJ, Laporte J, Kioschis P, Heyberger S, Kretz C, Poustka A, Mandel JL, Dahl N: X-linked myotubular myopathy: refinement of the gene to a 280-kb region with new and highly informative microsatellite markers. Hum Genet 98:178–81 (1996a).
  13. Hu LJ, Laporte J, Kress W, Dahl N: Prenatal diagnosis of X-linked myotubular myopathy: strategies using new and tightly linked DNA markers. Prenat Diagn 16:231–237 (1996b).
  14. Hu LJ, Laporte J, Kress W, Kioschis P, Siebenhaar R, Poustka A, Fardeau M, Metzenberg A, Janssen EA, Thomas N, Mandel JL, Dahl N: Deletions in Xq28 in two boys with myotubular myopathy and abnormal genital development define a new contiguous gene syndrome in a 430-kb region. Hum molec Genet 5:139–143 (1996c).
  15. Kioschis P, Rogner UC, Pick E, Klauck SM, Heiss N, Siebenhaar R, Korn B, Coy JF, Laporte J, Liechti-Gallati S, Poustka A: A 900-kb cosmid contig and 10 new transcripts within the candidate region for myotubular myopathy (MTM1). Genomics 33: 365–373 (1996).
  16. Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, Coy JF, Klauck SM, Poustka A, Dahl N: A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nature Genet 13:175–182 (1996).

    External Resources

  17. Laporte J, Kioschis P, Hu LJ, Kretz C, Carlsson B, Poustka A, Mandel JL, Dahl N: Cloning and characterization of an alternatively spliced gene in proximal Xq28 deleted in two patients with intersexual genitalia and myotubular myopathy. Genomics 41:458–462 (1997).

    External Resources

  18. Laporte J, Guiraud-Chaumeil C, Tanner SM, Blondeau F, Hu LJ, Vicaire S, Liechti-Gallati S, Mandel JL: Genomic organization of the MTM1 gene implicated in X-linked myotubular myopathy. Eur J hum Genet 6:325–330 (1998).
  19. Lehesjoki AE, Sankila EM, Miao J, Somer M, Salonen R, Rapola J, de la Chapelle A: X-linked neonatal myotubular myopathy: one recombination detected with four polymorphic DNA markers from Xq28. J med Genet 27:288–291 (1990).

    External Resources

  20. Maraschio P, Tupler R, Barbierato L, Dainotti E, Larizza D, Bernardi F, Hoeller H, Garau A, Tiepolo L: An analysis of Xq deletions. Hum Genet 97:375–381 (1996).

    External Resources

  21. OMIM: Online Mendelian Inheritance in Man, Johns Hopkins University, Baltimore, MD. MIM number *310400, date edited 23/3/1998. World Wide Web URL:
  22. Reichelt T: Customized probes for fluorescence in situ hybridization (FISH) from various sources – a universal and fast PCR-based protocol using the ExpandTM High Fidelity system. Boehringer Mannheim Biochemica Information 101:32–35 (1997).
  23. Ried T, Mahler V, Vogt P, Blonden L, van Ommen GJ, Cremer T, Cremer M: Direct carrier detection by in situ suppression hybridization with cosmid clones of the Duchenne/Becker muscular dystrophy locus. Hum Genet 85:581–586 (1990).

    External Resources

  24. Smolenicka Z, Laporte J, Hu L, Dahl N, Fitzpatrick J, Kress W, Liechti-Gallati S: X-linked myotubular myopathy: refinement of the critical gene region. Neuromuscul Disord 6:275–281 (1996).
  25. Telenius H, Carter NP, Bebb CE, Nordenskjöld M, Ponder BA, Tunnacliffe A: Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 13:718–725 (1992).
  26. Thomas NST, Williams H, Cole G, Roberts K, Clarke A, Liechti-Gallati S, Braga S, Gerber A, Meier C, Moser H, Harper PS: X-linked neonatal centronuclear/myotubular myopathy: evidence for linkage to Xq28 DNA marker loci. J med Genet 27:284–287 (1990).

    External Resources

  27. Van Wijngaarden GK, Fleury P, Bethlem J, Meijer AEFH: Familial “myotubular” myopathy. Neurology 19:901–908 (1969).

    External Resources

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50